Walsh & Associates’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.3K Hold
78
– – 0.02% 148
2026
Q2
$30.2K Hold
78
– – 0.02% 144
2026
Q1
$22.8K Hold
78
– – 0.02% 151
2025
Q4
$27.3K Hold
78
– – 0.03% 143

Other funds holding ELV

Walsh & Associates's ELV Position: Q3 2026 in Review

Walsh & Associates held its Elevance Health (ELV) position steady in Q3 2026 at 78 shares worth $30.3K. The position accounts for 0.02% of the portfolio, ranked #148.

Walsh & Associates first reported a position in ELV in Q4 2025 and has held it in 4 quarters since. 1,627 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Walsh & Associates held 78 shares of Elevance Health worth $30.3K as of Q3 2026.
  • Walsh & Associates left its Elevance Health share count unchanged in Q3 2026.
  • Elevance Health made up 0.02% of Walsh & Associates's portfolio in Q3 2026, its #148 holding.
  • Walsh & Associates first reported a position in Elevance Health in Q4 2025 and has held it in 4 quarters since.
  • 1,627 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.